In light of the public interest concerns involved, Unified Patents is seeking prior art or other grounds of invalidity for claim 1 of US 8,283,155 B2, which has been asserted by non-practicing entity Labrador Diagnostics, LLC, a NPE owned by Fortress Investment Group. The patents were originally owned by Theranos, the now-defunct diagnostics company run by Elizabeth Holmes—here listed as the lead inventor. The '155 patent purport to cover "portable medical devices that allow real-time detection of analytes from a biological fluid." Labrador has asserted these patents in U.S. district court against BioFire Diagnostics, LLC and bioMerieux S.A. and has sought an injunction to prevent them from making, selling, or using their testing kits. The complaints from district court can be found here: https://drive.google.com/open?id=1HTxQFDkr6Lvx0KygDE7BFb_f7I53-38G Also, APEX STANDARDS, a standard essentiality and patent validity analysis provider has shared US and non-US prior arts as well as corresponding claim charts against the two patents. Interested professionals may take them and craft work products from there. The link can be found here: http://apexstandards.com/US8283155B2/ In light of the serious public interest involved, Unified is not offering monetary reward for this contest, but will publish the results and the name of the searcher (if so desired). ** PLEASE READ THE RULES FOR THIS CONTEST BEFORE YOU DECIDE TO PARTICIPATE. ** ** TO QUALIFY FOR CONSIDERATION, A CLAIM CHART IS REQUIRED. ** ** PRIOR ART THAT HAS BEEN PREVIOUSLY CITED DURING PROSECUTION WILL NOT BE CONSIDERED. **